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Background 
• Postoperative respiratory complications occur in 1.03% of surgery 
patients with an average costs of $62,704 per patient, per event.1,2  
• Post-operative respiratory failure is often secondary to a concurrent 
severe complication, such as cardiac arrest, sepsis, pneumonia, 
aspiration, or pulmonary embolism.3 
• Isolated perioperative reintubation (IPR), defined as unplanned 
intubation in the first 24 hours of surgery without concurrent 
complications, has not been well characterized in the literature. 
• IPR likely occurs due to one or a combination of the following3,4:  
• Opioid overdose 
• Over-sedation 
• Residual paralysis 
• Fluid overload.  
• IPR represents a rare but possibly preventable cause for respiratory 
failure in the immediate postoperative period.  
  
    
Objectives  
1. We aim to characterize IPR nationally through a retrospective 
review of the National Surgical Quality Improvement Program 
participant user file (NSQIP PUF).  
2. Identify risk factors for IPR including analysis of procedure type 
and preoperative characteristics. 
• Chi-squared analysis identified 22 patient covariates and 18 CPT 
procedure groups that were associated with IPR (p<0.1) and 
included in the multivariable analysis.  
• Multivariable logistic regression analysis identified 12 patient 
factors and 8 operation types significantly associated with an 
elevated likelihood of IPR (p<0.05).  
Next Steps 
• Perform institutional review of IPR events and compare to national 
trends and benchmarks.  This will allow us to better understand: 
• Interplay and overlap of underlying etiologies. 
• Cost an average IPR event. 
• Combining the identified risk factors with physiologic parameters 
during emergence from anesthesia to help develop a high risk 
pulmonary pathway in the immediate perioperative period. 
• Traditionally, neostigmine has been used to promote anesthesia 
reversal in high risk patients 
• New, novel neuromuscular blockade reversal agents have 
demonstrated more effective at reversing the neuromuscular 
blockade than neostigmine, albeit at a higher price. 
• As the price for neostigmine rises, and becomes more comparable 
to these new agents, it may become beneficial to treat high risk 
groups, such as the ones identified in our study, with the newer 
agents. 
• Develop and validate robust anesthesia and surgery outcomes. 
• Many outcomes require appropriate patient selection, pre-
operative optimization, and intra-operative management by 
anesthesia. 
• Outcomes such as IPR require close coordination and 
collaboration between anesthesia and surgery. 
• Sharing and benchmarking outcomes like these may help to 
promote collaboration for improved outcomes in these two 
specialties 
References 
1. Dimick JB, Chen SL, Taheri P a, et al. Hospital costs associated with surgical 
complications: a report from the private-sector National Surgical Quality 
Improvement Program. J. Am. Coll. Surg. 2004;199:531–7. 
doi:10.1016/j.jamcollsurg.2004.05.276. 
2. Alvarez MP, Samayoa-Mendez AX, Naglak MC, et al. Risk Factors for 
Postoperative Unplanned Intubation: Analysis of a National Database. Am. Surg. 
2015;81:820–825. 
 3. Milgrom DP, Njoku VC, Fecher AM, et al. Unplanned intubation: when and 
why does this deadly complication occur? Surgery 2013;154:376–83. 
doi:10.1016/j.surg.2013.05.006. 
4. Craft J. Patient-controlled analgesia: Is it worth the painful prescribing 
process? Proc. Bayl. Univ. Med. Cent. 2010;23:434–438. 
 
Preventing Isolated Perioperative Reintubation:  Who is at highest risk?  
 
Tyler M. Bauer1, Adam P. Johnson1, Chris Wirtalla2, Jordan E. Goldhammer3, Rachel R. Kelz2, and Scott W. Cowan1  
 
1Department of Surgery, Thomas Jefferson University Hospital; 2Department of Surgery, University of Pennsylvania; 3Department of Anesthesia, Thomas Jefferson University Hospital 
Results 
Methods 
• The 2014 NSQIP PUF was queried for all observations. 
• Study and event exclusions were applied as below (Figure 1A and B) 
• Procedures were grouped by Current procedural terminology (CPT) 
code, as recommended in the NSQIP appendix B file. 
• IPR was analyzed with known risk factors and procedure grouping 
using chi square analysis (p < 0.001) 
• Multivariable logistic regression Analysis was used to analyze for 
independent risk factors (p < 0.05) 
• Inclusion into the multivariable analysis was based on a chi 
square p value < 0.1. 
 
Limitations 
• Retrospective review of registry data is limited to data collected by 
the registry and may not have generalizability outside of participants 
in the ACS NSQIP patient registry. 
• Since there is no explicit variable for IPR, it was inferred by 
exclusions.  Further chart review at an institutional level may be 
necessary to validate the application of the se exclusions for this 
purpose. 
Discussion 
• We identified a national IPR of 0.1% in all eligible patients.  
• Ten procedures demonstrate a higher than average likelihood of 
IPR, and two, spine and knee arthroplasty, demonstrate a lower 
likelihood. 
• TKA and Spine Surgeries had a odds ratio of < 0.01 (protective). 
We believe this was due to a low amount of onboard anesthetics 
and enhanced operative management of anesthesia with 
somatosensory evoked potentials  respectively. 
• Further chart review and prospective analysis may be required to 
understand the mechanism for increased likelihood of IPR in other 
general and vascular procedures. 
• Many of the patient comorbidities overlap with risk factors for  
931 POD 0 UI 
625 Isolated POD 0 UI 
5 Neurologic (CVA) day 0, 1, or 2 
74 SIRS/Sepsis day 0, 1, or 2 
25 Pneumonia day 0, 1, or 2 
109 Cardiac (MI/Cardiac arrest) day 0, 1, or 2 
88 Vent Dependence at any time 
5 Pulmonary Embolism day 0, 1, or 2 
750,937 Cases in 2014 PUF 
706,209 Cases included in analysis 
2,750 On ventilator pre-op 
36,833 SIRS/Sepsis pre-op 
1,736 SSI Pre-op 
1,398 Pneumonia pre-op 
73,778 Not under general anesthesia 
Figure 1A: Study Exclusions  Figure 1B: Event Exclusions  
IPR Covariate OR P>|z| 95% CI 
Preoperative risk factor 
Age (>60 years) 1.44 <0.001 1.2 - 1.72 
Current smoker 1.25 0.023 1.03 - 1.51 
Report of dyspnea (rest and 
moderate) 1.76 <0.001 1.41 - 2.19 
Ascites (in prev 30days) 2.22 0.039 1.04 - 4.74 
COPD (Severe) 1.88 <0.001 1.49 - 2.37 
CHF(in prev 30 days) 1.89 0.002 1.27 - 2.81 
HTN 1.44 <0.001 1.19 - 1.75 
Transfusion preoperatively in 
last 72 hours 2.87 <0.001 1.94 - 4.26 
Wound classification (>/= 2) 1.32 0.007 1.08 - 1.62 
ASA classification (>/= 3) 3.10 <0.001 2.44 - 3.93 
Operative time (>3 hours) 1.65 <0.001 1.38 - 1.99 
African American 1.34 0.013 1.06 - 1.7 
Procedure 
Colectomy 1.45 0.009 1.1 - 1.92 
Esophagectomy 3.79 <0.001 1.95 - 7.36 
CAS 7.92 0.041 1.08 - 57.89 
EVAR 2.37 <0.001 1.5 - 3.73 
Aorticoilliac (open) 2.36 0.001 1.4 - 3.98 
Spine 0.62 0.046 0.39 - 0.99 
Nephrectomy 1.74 0.026 1.07 - 2.84 
Cystectomy 2.07 0.039 1.04 - 4.12 
TKA 0.31 0.010 0.13 - 0.75 
Hip Fracture 1.79 0.020 1.1 - 2.93 
